20/20 Onsite

07/25/2025

New research is shedding light on how GLP-1s like semaglutide may impact eye health. We compiled the latest data on ocular risks such as NAION and AMD, and what it means for patients and providers.

📚 Dive into the findings and learn how proactive vision monitoring could support safer, more informed treatment and decisions:
🔗

Know the urgent ocular risks associated with GLP‑1 receptor agonists in clinical trials and how to mitigate Semaglutide eye risks with strategies for GLP‑1 clinical trial eye safety.

07/24/2025

Integrating imaging early in clinical trial design is a game changer.

Prioritizing precision and standardization from the outset, reduces variability, safeguards ocular endpoints, and streamlines regulatory submissions.

A proactive imaging strategy means fewer delays and more robust data.

Learn more in our latest article: https://hubs.ly/Q03sKq3j0

07/23/2025

Last week, our crew volunteered at BINA Farm Center. We got our hands dirty and were rewarded with a visit from Angel the mini horse. 🐴

BINA Farm Center has an inclusive mission of bringing people together of all ages, those both with and without disabilities, through clinical, therapeutic, and recreational programs that provide equine-assisted services, gardening, and vocational opportunities.

Grateful for the chance to support such a meaningful organization!

07/22/2025

Will you be at OIS Retina next week?

Katie Sigg, Account Executive, Life Sciences, will be there meeting with sponsors and CROs to discuss how we can help boost recruitment, streamline enrollment, reduce site burden, and maximize clinical trial performance from day one.

📩 Let’s connect at OIS. https://hubs.ly/Q03wwxKG0

07/21/2025

Some of the team was out in the South End last week supporting the Boston Cathedral of the Holy Cross! They went above and beyond, passing out flyers the entire morning to make sure every exam spot was filled. 💛

We’re inspired by their dedication to serving the community and grateful to be part of it. Here’s to more events together!

07/18/2025

20/20 Onsite is hiring an Ophthalmic Technician!

At 20/20 Onsite, we believe healthcare should meet people where they are literally. That’s why our Mobile Vision Clinics deliver eye exams to schools, offices, and clinical research sites nationwide.

We’re looking for a full-time Ophthalmic Technician based near Phoenix, AZ or Salt Lake City, UT to:
🔹 Perform comprehensive eye exams in our mobile clinics
🔹 Travel nationwide as part of a tight-knit clinical team
🔹 Deliver top-tier patient care and operational excellence
🔹 Help power clinical research and community-based vision programs

This role is 100% travel, we handle the logistics, you focus on care.

Why you’ll love it here:
➕ 100% paid travel to deliver care where it’s needed most
➕ Work with advanced diagnostic tools inside a mobile clinic
➕ Direct exposure to clinical research and healthcare innovation
➕ Every day is different—new cities, new patients, real impact
➕ Be part of a close-knit team redefining how care is delivered

We’re looking for:
✔️ Has experience in ophthalmic or optometric testing (certification is a bonus, not a must)
✔️ Communicates clearly and compassionately with patients
✔️ Can confidently drive a mobile unit across states (no CDL needed)
✔️ Stays calm under pressure and organized with clinical data
✔️ Learns fast, adapts easily, and brings a problem-solving mindset
✔️ Is flexible to work beyond the typical 9–5 when needed

Sounds like you or someone you know?

Apply or tag a tech who’s ready to take their career mobile:

👉 https://hubs.ly/Q03xHLdx0

07/15/2025

Clinical trials on average lose up to 30% of participants before completion.

With 20/20 Onsite’ Mobile Vision Clinics (MVCs), that number has been proven to drop to just 9%. That’s a 70% reduction in dropout—driven by better access and less patient burden. It’s quality ocular endpoint protection delivered right at your point of need.

When patients stay, trials succeed.

Learn more about trial design strategies to improve patient retention and protect ocular endpoints: https://hubs.ly/Q03sc8-R0

07/14/2025

July is Dry Eye Awareness Month, and the data tells a story researchers can’t ignore:

✔️ 16.4 million Americans affected
✔️ Women are twice as likely to develop dry eye
✔️ Common medications can trigger symptoms
✔️ Left untreated, it can impact vision and trial outcomes

Learn more about the condition from our partners at Prevent Blindness: https://hubs.ly/Q03wvwDy0

07/11/2025

These aren’t just numbers, they’re how we protect ocular endpoints for clinical trials.

📍 45 trials supported
📍 85,000+ assessments completed
📍 91% patient retention rate
📍 100% timeline compliance

With 20/20 Onsite, results move your trial forward—on time, every time.

Learn about our clinical trial solutions: https://hubs.ly/Q03vfbSP0

07/10/2025

Heading to the OIS Retina Innovation Summit in Long Beach, CA, this month?

So is Katie Sigg, our Life Sciences Account Executive at 20/20 Onsite! She’s connecting with clinical operations teams focused on solving challenges around patient access, enrollment, and retention in ophthalmology clinical trials.

We bring full-scale ophthalmic assessments to the point of need, decreasing screen failure rates and enrollment timelines while fast-tracking trials!

Let’s connect to explore how bringing assessments to patients can boost recruitment, streamline enrollment, reduce site burden, and maximize clinical trial performance from day one.

👉 https://hubs.ly/Q03wws0D0

07/09/2025

“Access to healthcare is a chronic and pressing challenge, especially in rural and underserved communities.”

Healthcare access is a challenge our CEO, Sonali Bloom, unpacks in her latest Forbes piece. And it’s the one we’re solving at 20/20 Onsite—by bringing trials to the patients instead of the other way around.

🚌Our Mobile Vision Clinics deliver high-quality care at the point of need.
📈 Our clients report up to 80% reduction in patient travel burden.
🧪 Our Quality Ocular Endpoint Protection ensures no compromise on data integrity.

Access isn’t just about geography. It’s about equity, speed, and success.

Read the full article in Forbes:
https://hubs.ly/Q03s4lsk0

07/07/2025

Site Variability Delays Trials and Ruins Results.

Even when sites follow protocol, assessment inconsistency can threaten your outcomes. 20/20 Onsite ensures every ocular assessment meets the highest standards, eliminating site-to-site variability.

Get reliable, accurate ocular data—no matter where your patients are.

Complimentary protocol review https://hubs.ly/Q03w1x_b0